Study for prevention of autoimmune non-insulin-dependent diabetes mellitus with sitagliptin (SPAN-S)
Not Applicable
- Conditions
- Diabetes mellitus (GAD Ab positive non-insulin dependent diabetes mellitus)
- Registration Number
- JPRN-UMIN000003693
- Lead Sponsor
- Saitama Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
pregnant or planning to be pregnant moderate renal dysfunction: Ccr < or = 50 mL/min, or serum Cr > or = 1.5 mg/dL (male) or 1.3 mg/dL (female) severe complication that is inappropriate for trial physician's judgement
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HbA1c values, and fraction and period from registration of patients whose HbA1c values become 9.4 %(NGSP) or above
- Secondary Outcome Measures
Name Time Method glucose and C-peptide values in annual 75 g OGTTs body weight blood pressure islet autoantibodies (GAD Ab, IA-2 Ab, IAA, ZnT8 Ab) fasting glucose values fasting C-peptide values